MedTrace Logo

Epoetin Beta in Treating Anemia in Patients With Cervical Cancer

NCT00046969 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2013-05-30

No results posted yet for this study

Summary

RATIONALE: Epoetin beta may stimulate red blood cell production to prevent or control anemia in patients treated with chemotherapy and radiation therapy.

PURPOSE: Randomized phase IV trial to determine the effectiveness of epoetin beta in treating anemia in patients who are receiving cisplatin and radiation therapy for stage IIB, stage III, or stage IVA cervical cancer.

Conditions

Interventions

BIOLOGICAL

epoetin beta

DRUG

cisplatin

RADIATION

brachytherapy

RADIATION

radiation therapy

Sponsors & Collaborators

  • AGO Study Group

    lead OTHER

Principal Investigators

  • Heinz Koelbl, MD · Martin-Luther-Universität Halle-Wittenberg

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-07-31
Completion
2007-06-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00046969 on ClinicalTrials.gov